ContagionLive | The Infectious Diseases Society of America (IDSA) has worked hard to raise awareness about the antimicrobial resistance crisis and the need for progress in developing medicines to treat resistant infections. In 2010, IDSA issued a call for 10 new antibacterial agents by the year 2020. That 10×’20 goal has been achieved with 14 new antibiotics becoming available. However, these medications are floundering in a failing market. The broken market needs to be fixed, now. In this analysis, Dr. Helen Boucher, director of the Tufts Center for Integrated Management of Antimicrobial Resistance, urges the US government to take action.